Series A - Clasp Therapeutics
Investment Firm
Overview
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Announced Date
Mar 20, 2024
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Third Rock Ventures
Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.
Novo Holdings
Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.
Catalio Capital Management
Catalio Capital Management is a debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.
Participant Investors
9
Round Details and Background
Clasp Therapeutics raised $150000000 on 2024-03-20 in Series A
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 20, 2024 |  Series A - Clasp Therapeutics | 9 | - | 150.0M |
Recent Activity
There is no recent news or activity for this profile.